Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7715407 | 0.89 | KDM4E (0.37) | KDM4ELMNAALDH1A1EPHX2HPGD | |
| SCHEMBL12256170 | 0.82 | KDM4E (0.37) | KDM4ELMNAALDH1A1EPHX2 | |
| SCHEMBL5182162 | 0.80 | KDM4E (0.42) | KDM4ELMNAALDH1A1EPHX2HPGD | |
| SCHEMBL1299179 | 0.79 | KDM4E (0.40) | KDM4ELMNAALDH1A1EPHX2 | |
| SCHEMBL301572 | 0.79 | KDM4E (0.40) | KDM4ELMNAALDH1A1EPHX2 | |
| SCHEMBL13791007 | 0.79 | KDM4E (0.40) | KDM4ELMNAALDH1A1EPHX2 | |
| SCHEMBL4741820 | 0.79 | ALDH1A1 (0.39) | KDM4ELMNAALDH1A1EPHX2 | |
| SCHEMBL7713924 | 0.79 | KDM4E (0.35) | KDM4ELMNAALDH1A1EPHX2 | |
| SCHEMBL7718255 | 0.79 | KDM4E (0.33) | KDM4ELMNA | |
| SCHEMBL14449006 | 0.79 | KDM4E (0.47) | KDM4ELMNAALDH1A1EPHX2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313523-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS, PBC | 2025-10-09 | — | — | US | disclosed |
| EP-2248839-B1 | CRYSTALLINE NORBORNENE RING-OPENING POLYMER HYDRIDE AND MOLDED ARTICLE OF SAME | ZEON CORP (JP) | 2018-03-28 | — | — | EP | disclosed |
| EP-2128196-B1 | POLYMER COMPOSITION AND USE THEREOF | ZEON CORP (JP) | 2016-10-26 | — | — | EP | disclosed |
| US-8277914-B2 | Polymer composition and use thereof | ZEON CORPORATION (JP) | 2012-10-02 | — | — | US | disclosed |
| US-8053531-B2 | Hydrogenated crystalline norbornene ring-opening polymer and molded article | ZEON CORPORATION (JP) | 2011-11-08 | — | — | US | disclosed |
| US-20110021731-A1 | HYDROGENATED CRYSTALLINE NORBORNENE RING-OPENING POLYMER AND MOLDED ARTICLE | ZEON CORPORATION (JP) | 2011-01-27 | — | — | US | disclosed |
| EP-2248839-A1 | CRYSTALLINE NORBORNENE RING-OPENING POLYMER HYDRIDE AND MOLDED ARTICLE OF SAME | Zeon Corporation (JP) | 2010-11-10 | — | — | EP | disclosed |
| US-20100092712-A1 | POLYMER COMPOSITION AND USE THEREOF | ZEON CORPORATION (JP) | 2010-04-15 | — | — | US | disclosed |
| EP-2128196-A1 | POLYMER COMPOSITION AND USE THEREOF | ZEON CORPORATION (JP) | 2009-12-02 | — | — | EP | disclosed |
| US-20080199805-A1 | PHOTOSENSITIVE COMPOSITIONS EMPLOYING SILICON-CONTAINING ADDITIVES | FUJIFILM ELECTRONIC MATERIALS. U.S.A., INC. | 2008-08-21 | — | — | US | disclosed |
| WO-2008098189-A1 | PHOTOSENSITIVE COMPOSITIONS EMPLOYING SILICON-CONTAINING ADDITIVES | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2008-08-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250313523-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CYP8B1, CYP1B1, BBOX1 | KDM4E 3949/4885LMNA 2153/4885ALDH1A1 117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.